Skip to main content

Articles

Conference Correspondent, ASH 2016 - Chronic Lymphocytic Leukemia
PD-1 Blockade with Pembrolizumab in Relapsed CLL Including Richter’s Transformation: An Updated Report from a Phase 2 Trial (MC1485)
Read More
Conference Correspondent, ASH 2016 - Chronic Lymphocytic Leukemia
Integrated and Long-Term Safety Analysis of Ibrutinib in Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Read More
Conference Correspondent, ASH 2016 - Chronic Lymphocytic Leukemia
Identification of Baseline Characteristics That Predict Good Outcome of alloHCT in Young CLL Patients - A Retrospective Analysis from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Read More
Conference Correspondent, ASH 2016 - Chronic Lymphocytic Leukemia
Preclinical Analyses Support Clinical Investigation of Combined Anti-CD19 CAR-T Cell, JCAR017 with Ibrutinib for the Treatment of Chronic Lymphocytic Leukemia
Read More
Conference Correspondent, ASH 2016 - Chronic Lymphocytic Leukemia
Long-Term Follow-Up of Chlorambucil plus Rituximab Combination as Frontline Therapy for Elderly and/or Unfit Patients with CLL, Including Risk Stratification
Read More
Conference Correspondent, ASH 2016 - Chronic Lymphocytic Leukemia
Management and Outcomes of Atrial Fibrillation in Patients Receiving Ibrutinib for Hematologic Malignancies at a Single Center
Read More
Conference Correspondent, ASH 2016 - Chronic Lymphocytic Leukemia
Initial Results of a Multicenter, Phase II Study of Ibrutinib plus FCR (iFCR) as Frontline Therapy for Younger CLL Patients
Read More
Conference Correspondent, ASH 2016 - Chronic Lymphocytic Leukemia
11q Deletion (del11q) Is Not a Prognostic Factor for Adverse Outcomes for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Treated with Ibrutinib: Pooled Data from 3 Randomized Phase 3 Studies
Read More
Conference Correspondent, ASH 2016 - Chronic Lymphocytic Leukemia
Outcomes of Ibrutinib Therapy by Age in Patients with CLL/SLL: Analyses from Phase 3 Trial Data (RESONATE and RESONATE-2)
Read More
Conference Correspondent, ASH 2016 - Chronic Lymphocytic Leukemia
Nivolumab Combined with Ibrutinib for CLL and Richter Transformation: A Phase II Trial
Read More
Page 104 of 245
Results 1031 - 1040 of 2441